FDA bans imports from Sun Pharma plant in India crackdown #pharmacology #companies


Posted On Nov 26 2017 by

#sun pharma

#

FDA bans imports from Sun Pharma plant in India crackdown

By Zeba Siddiqui and Sumeet Chatterjee | MUMBAI

MUMBAI (Reuters) – The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector.

The FDA has imposed a rash of regulatory sanctions on Indian generic makers in the last year, triggering concerns about the quality of the medicines supplied by the $14 billion industry to countries including the United States, the biggest market.

India is second only to Canada as a drug exporter to the United States, where it supplies about 40 percent of generic and over-the-counter drugs.

“The FDA is becoming more stringent. It’s a learning curve for everyone. You have to invest more,” said B Editing by Tony Munroe and Jeremy Laurence)


Last Updated on: November 25th, 2017 at 10:21 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *